On Monday, Moderna Inc (NASDAQ: MRNA) opened lower -2.51% from the last session, before settling in for the closing price of $26.67. Price fluctuations for MRNA have ranged from $23.15 to $145.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 121.86% over the last five years. Company’s average yearly earnings per share was noted -8.51% at the time writing. With a float of $342.49 million, this company’s outstanding shares have now reached $387.00 million.
The firm has a total of 5800 workers. Let’s measure their productivity. In terms of profitability, gross margin is 52.55%, operating margin of -118.04%, and the pretax margin is -107.82%.
Moderna Inc (MRNA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Moderna Inc is 11.44%, while institutional ownership is 72.20%. The most recent insider transaction that took place on Jun 11 ’25, was worth 8,736. In this transaction Director of this company sold 312 shares at a rate of $28.00, taking the stock ownership to the 580 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 312 for $28.00, making the entire transaction worth $8,736.
Moderna Inc (MRNA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.72% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Check out the current performance indicators for Moderna Inc (MRNA). In the past quarter, the stock posted a quick ratio of 4.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.72, a number that is poised to hit -2.96 in the next quarter and is forecasted to reach -7.47 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Analysing the last 5-days average volume posted by the [Moderna Inc, MRNA], we can find that recorded value of 8.66 million was lower than the volume posted last year of 11.43 million. As of the previous 9 days, the stock’s Stochastic %D was 28.33%. Additionally, its Average True Range was 1.47.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 12.81%, which indicates a significant decrease from 14.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.77% in the past 14 days, which was lower than the 72.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.27, while its 200-day Moving Average is $41.07. Now, the first resistance to watch is $26.68. This is followed by the second major resistance level at $27.36. The third major resistance level sits at $27.97. If the price goes on to break the first support level at $25.39, it is likely to go to the next support level at $24.78. Should the price break the second support level, the third support level stands at $24.10.
Moderna Inc (NASDAQ: MRNA) Key Stats
There are currently 386,742K shares outstanding in the company with a market cap of 10.06 billion. Presently, the company’s annual sales total 3,236 M according to its annual income of -3,561 M. Last quarter, the company’s sales amounted to 108,000 K and its income totaled -971,000 K.
